Skip to main content Back to Top
Advertisement

6/27/2017

Tetracaine Hydrochloride Ophthalmic Drops

Reason for the Shortage

    • Altaire has tetracaine ophthalmic drops available.
    • Novartis has tetracaine ophthalmic drops available.
    • Ocusoft has Tetravisc and Tetravisc Forte available.
    • Valeant has tetracaine ophthalmic drops available.

Available Products

    • Altacaine ophthalmic drops, Altaire, 0.5%, 15 mL bottle, 1 count, NDC 59390-0181-13
    • Tetravisc ophthalmic drops, OCuSOFT, 0.5%, 0.6 mL unit-dose container, 12 count, NDC 54799-0505-01
    • Tetravisc ophthalmic drops, OCuSOFT, 0.5%, 5 mL bottle, 1 count, NDC 54799-0505-05
    • Tetravisc Forte ophthalmic drops, OCuSOFT, 0.5%, 0.6 mL unit-dose container, 12 count, NDC 54799-0504-01
    • Tetravisc Forte ophthalmic drops, OCuSOFT, 0.5%, 5 mL bottle, 1 count, NDC 54799-0504-05
    • Tetracaine ophthalmic drops, Novartis, 0.5%, 4 mL bottle, 1 count, NDC 00065-0741-14
    • Tetracaine ophthalmic drops, Valeant, 0.5%, 15 mL bottle, 1 count, NDC 24208-0920-64

Updated

Updated June 27, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 7, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins